Absorbance was measured at 450 nm at an EnSpire multimode plate reader (PerkinElmer, Singapore)
In cell experiments, GLP-1 was found to have more mechanisms that may inhibit liver fat synthesis, such as FAM3A, NRF2, NaB, SHP1/AMPK, NLRP3, FGF21, IRS2, and other signaling pathways, which also provided direct evidence for the role of GLP-1R in the regulation of lipid metabolism in the liver
Notably, after a 4-week washout period these beneficial effects diminished, with the exception of clinical severity scores
Thermodynamic regulation of human short-chain acyl-CoA dehydrogenase by substrate and product binding
Essentially, an evolution of BPC 157 without its drawbacks
Improved nanocarrier technology targeting the CNS is a critical step towards treating disorders characterized by the coexistence of inflammation and oxidative stress where the immunologic properties of GSH show therapeutic benefit